| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| McConnon Thomas | Director | C/O GOOSEHEAD INSURANCE, INC., 1500 SOLANA BLVD., BLDG 4, STE 4500, WESTLAKE | /s/ John O'Connor, as Attorney-in-Fact for Thomas McConnon | 03 Dec 2025 | 0001908314 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GSHD | Class A Common Stock | Sale | -$5M | -68K | -20.05% | $73.60 | 271K | 01 Dec 2025 | See footnote | F1, F2 |
| transaction | GSHD | Class A Common Stock | Sale | -$127K | -1.7K | -0.63% | $74.56 | 269K | 01 Dec 2025 | See footnote | F2, F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.49 to $74.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F2 | Thomas McConnon, a member of the Goosehead Insurance, Inc. ("Goosehead") board of directors, is the Chief Investment Officer of Whitebark Investors LP ("Whitebark") and may be deemed a beneficial owner of shares ("Shares") of Goosehead Class A Common Stock managed by Whitebark. The Shares reported herein were sold by Whitebark for its client, Wildcat Public Equity Partners, LLC. Mr. McConnon disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.49 to $74.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |